Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/20788
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Antibodies, Monoclonal/*therapeutic use,Antirheumatic Agents/*therapeutic use,Arthritis, Rheumatoid/*drug therapy/immunology,Blood Sedimentation,C-Reactive Protein/analysis,Chronic Disease,Cyclosporine/*therapeutic use,Drug Administration Schedule,Drug Therapy, Combination,Female,Humans,Infusions, Intravenous,Male,Middle Aged,Treatment Outcome
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/20788
ISSN: 0003-4967
Link: http://www.ncbi.nlm.nih.gov/pubmed/12176808
http://ard.bmj.com/content/61/9/822.full.pdf
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Temekonidis-2002-Infliximab treatment.pdf167.2 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons